What is the catalog number for MAP1LC3A/Lc3A Rabbit Monoclonal Antibody?

The catalog number for MAP1LC3A/Lc3A Rabbit Monoclonal Antibody is orb547780.

What sizes are available for MAP1LC3A/Lc3A Rabbit Monoclonal Antibody?

MAP1LC3A/Lc3A Rabbit Monoclonal Antibody is available in the following size(s): 100 µL.

Is MAP1LC3A/Lc3A Rabbit Monoclonal Antibody in stock?

MAP1LC3A/Lc3A Rabbit Monoclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

MAP1LC3A/Lc3A Rabbit Monoclonal Antibody

Anti-MAP1LC3A/Lc3A Rabbit Monoclonal Antibody. Tested in WB, IHC, ICC/IF, IP applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Microtubule-associated proteins 1A/1B light chain 3A; Autophagy-related protein LC3 A; Autophagy-related ubiquitin-like modifier LC3 A; MAP1 light chain 3-like protein 1; MAP1A/MAP1B light chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-associated protein 1 light chain 3 alpha; MAP1LC3A

UniProt

Q9H492

Reactivity

Human, Mouse, Rat

Immunogen

A synthesized peptide derived from human MAP1LC3A

Target

Microtubule-associated protein 1 light chain 3 alpha

Clonality

Monoclonal

Clone

BIEJX35

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Cell Biology, Metabolism Research, Signal Transduction

Purification

Affinity-chromatography

Concentration

0.5mg/ml

Dilution

WB 1:5000-1:20000 IHC 1:50-1:200 ICC/IF 1:50-1:200 IP 1:50

Form

Liquid

Molecular Weight

47 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ICC, IF, IHC, IP, WB

Host or Source

Rabbit

Preservative

Rabbit IgG in stabilizing components, phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.